fda compounding semaglutide warning letters october 2025 Compound versions of GLP-1 drugs for weight loss halted by FDA Sends Warning Letters to

You should also reach out if you experience: TRT should be monitored

Clinically significant weight loss for many people while on the medicine Better metabolic health, including improved A1c (a blood test that shows your average blood sugar level over the past two-to-three months), blood pressure and cholesterol for appropriate patients A non-surgical approach you can start with medical supervision Combining Bariatric Surgery and GLP-1s Some people use GLP-1 medications before surgery to improve readiness (i.e., better control over conditions such as diabetes) and after surgery to manage plateaus or weight regain

The semaglutide vs tirzepatide comparison provides a detailed head-to-head analysis

More in hot weather

Therapeutic strategies targeting the microbiome could modulate disease progression by improving gut permeability, reducing endotoxin-producing bacteria, and altering bile acid metabolism